ITEAX | VIVIX | ITEAX / VIVIX | |
Total Expense Ratio | 1.21 | 0.04 | 3,025% |
Annual Report Gross Expense Ratio | 1.24 | 0.04 | 3,100% |
Fund Existence | 22 years | 27 years | - |
Gain YTD | -3.352 | 9.748 | -34% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 281M | 208B | 0% |
Annual Yield % from dividends | 1.36 | 2.09 | 65% |
Returns for 1 year | -7.35 | 4.64 | -158% |
Returns for 3 years | 10.80 | 42.98 | 25% |
Returns for 5 years | 27.90 | 71.78 | 39% |
Returns for 10 years | -12.55 | 129.40 | -10% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ASIRX | 12.25 | 0.33 | +2.77% |
Alger Small Cap Growth Institutional R | |||
SMDRX | 20.10 | 0.24 | +1.21% |
Hartford Schroders US MidCap Opps SDR | |||
HGXFX | 17.40 | 0.12 | +0.69% |
Hartford Global Impact F | |||
LGMAX | 26.71 | 0.12 | +0.45% |
Loomis Sayles Global Allocation A | |||
FNCMX | 288.93 | N/A | N/A |
Fidelity Nasdaq Composite Index |